-
Signature
-
/s/ Pamela Sergeeff, Attorney-in-Fact
-
Issuer symbol
-
FRSH
-
Transactions as of
-
28 Feb 2024
-
Net transactions value
-
-$94,832
-
Form type
-
4
-
Filing time
-
01 Mar 2024, 17:43:09 UTC
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
FRSH |
Class A Common Stock |
Conversion of derivative security |
$0 |
+4,690 |
+27% |
$0.000000 |
22,077 |
01 Mar 2024 |
Direct |
|
| transaction |
FRSH |
Class A Common Stock |
Sale |
$94,832 |
-4,690 |
-21% |
$20.22 |
17,387 |
01 Mar 2024 |
Direct |
F1, F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
FRSH |
Restricted Stock Units |
Options Exercise |
$0 |
-7,810 |
-100% |
$0.000000* |
0 |
28 Feb 2024 |
Class B Common Stock |
7,810 |
|
Direct |
F3, F4 |
| transaction |
FRSH |
Restricted Stock Units |
Options Exercise |
$0 |
-1,570 |
-5.3% |
$0.000000 |
28,120 |
28 Feb 2024 |
Class B Common Stock |
1,570 |
|
Direct |
F3, F5 |
| transaction |
FRSH |
Class B Common Stock |
Options Exercise |
$0 |
+9,380 |
+14% |
$0.000000 |
75,004 |
28 Feb 2024 |
Class A Common Stock |
9,380 |
|
Direct |
F6 |
| transaction |
FRSH |
Class B Common Stock |
Conversion of derivative security |
$0 |
-4,690 |
-6.3% |
$0.000000 |
70,314 |
01 Mar 2024 |
Class A Common Stock |
4,690 |
|
Direct |
F6 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: